The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(6-(3-methyl-4-(2-(naphthalen-1-yloxy)acetyl)piperidin-1-yl)nicotinoyl)pyrrolidine-2-carboxamide ID: ALA2418939
PubChem CID: 73346115
Max Phase: Preclinical
Molecular Formula: C29H32N4O4
Molecular Weight: 500.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1CN(c2ccc(C(=O)N3CCCC3C(N)=O)cn2)CCC1C(=O)COc1cccc2ccccc12
Standard InChI: InChI=1S/C29H32N4O4/c1-19-17-32(27-12-11-21(16-31-27)29(36)33-14-5-9-24(33)28(30)35)15-13-22(19)25(34)18-37-26-10-4-7-20-6-2-3-8-23(20)26/h2-4,6-8,10-12,16,19,22,24H,5,9,13-15,17-18H2,1H3,(H2,30,35)
Standard InChI Key: UOVRUCQCDIYKSY-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
13.5221 -10.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3417 -10.1795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7493 -9.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3385 -8.7618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5158 -8.7662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1119 -9.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5631 -9.4694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9717 -10.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7853 -10.1788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1965 -9.4722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7880 -8.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9682 -8.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1924 -10.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0137 -9.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4209 -10.1825 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2947 -9.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8827 -8.7740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8896 -10.1894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2094 -8.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5994 -7.4766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8937 -7.8887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0676 -8.6872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5204 -9.2932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7207 -9.1248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7744 -10.0699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4238 -8.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2410 -8.7688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6511 -8.0619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4707 -6.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6493 -6.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2430 -7.3597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8779 -7.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4653 -8.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8682 -8.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6836 -8.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0943 -8.0687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6890 -7.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
3 7 1 0
9 13 1 0
10 14 1 0
14 15 2 0
6 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 17 1 0
23 24 1 0
23 25 2 0
22 23 1 0
14 26 1 0
26 27 1 0
27 28 1 0
28 33 2 0
32 29 2 0
29 30 1 0
30 31 2 0
31 28 1 0
32 33 1 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.60Molecular Weight (Monoisotopic): 500.2424AlogP: 3.44#Rotatable Bonds: 7Polar Surface Area: 105.83Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.86CX LogP: 3.32CX LogD: 3.32Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.53Np Likeness Score: -1.21
References 1. Norman DD, Ibezim A, Scott WE, White S, Parrill AL, Baker DL.. (2013) Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds., 21 (17): [PMID:23816044 ] [10.1016/j.bmc.2013.05.061 ]